Abstract
Introduction Palliative care (PC) has demonstrated benefits for life-limiting illnesses. Nowadays, there is a growing consensus about giving access these care services to non-cancer older patients. Bad survival prognosis and patients’ decline are working criterions to guide PC decision making.
Objective The main aim of this work is to propose complementary models based on machine learning approaches to predict frailty and mortality in older patients in the context of supporting PC decision making.
Methods The dataset used in this study is composed by 39,310 hospital admissions for 19,753 older patients (age >= 65) from January 1st, 2011 to December 30th, 2018. Predictive models based on Gradient Boosting Machines and Deep Neural Networks were implemented for binary one-year mortality classification, survival estimation and binary one-year frailty classification. Besides, we tested the similarity between mortality and frailty distributions.
Results The one-year mortality classifier achieved an AUC ROC of 0.87 [0.86, 0.87]; whereas the mortality regression model achieved an MAE of 333.13 [323.10, 342.49] days. Moreover, the one-year frailty classifier obtained an AUC ROC of 0.89 [0.88, 0.90].
Conclusions The performance of our one-year mortality model is competitive with the current state-of-the-art. Besides, to our knowledge, this is the first study predicting one-year frailty status based on a frailty index. We found mortality and frailty criteria are weakly correlated and have different distributions; therefore, we interpreted them as complementary assessment measurements for palliative care decision making. Predictive models are accessible as an online tool at http://demoiapc.upv.es. The models presented here may be part of decision support systems for care services in non-cancer older patients after their external validation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the InAdvance project (H2020-SC1-BHC-2018-2020 No. 825750.) and the ALBATROSS project (PID2019-104978RB-I00). Special thanks to Angel Sanchez-Garcia for his contributions to the website
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This procedure was assessed and approved by the Ethical Committee of the University and Polytechnic La Fe Hospital of Valencia (registration number: 2019-88-1).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Methodology reviewed to use bootstrap evaluation and added neural networks to compare the results of the original models
Data Availability
The data is NOT publicly available
Abbreviations
- PC
- Palliative Care
- FI
- Frailty Index
- ROC
- Receiver Operating Characteristic
- AUC ROC
- Area Under the Curve ROC
- GBM
- Gradient Boosting Machine
- 1YM
- One-year Mortality
